Polyporus

Polyporus (Polyporus umbellatus): A Comprehensive Reference

1. Identity and Nomenclature

Accepted Scientific Name and Taxonomy

Polyporus umbellatus (Pers.) Fries is a medicinal mushroom belonging to the family Polyporaceae, division Basidiomycotina. In 1801 Christiaan Hendrik Persoon first described this species, giving it the binomial name Boletus umbellatus. In his Systema Mycologicum of 1821, the Swedish mycologist Elias Magnus Fries transferred it to the genus Polyporus, establishing its currently accepted scientific name. Recognized synonyms include Boletus umbellatus Pers., Sclerotium giganteum Rostr., Grifola umbellata (Pers.) Pilát, and Dendropolyporus umbellatus (Pers.) Jülich.

Common Names

The species is an edible mushroom also called the umbrella polypore. In Traditional Chinese Medicine (TCM) it is known as Zhuling (猪苓; pinyin: Zhū Líng), and in Japan it is referred to as Chorei. The medicinal form is prepared from the dried sclerotia of Polyporus umbellatus (Pers.) Fries (Polyporaceae). It is distributed in Asia, Europe, and North America, and is an important TCM used in China and other countries for centuries.

Morphology and Natural Source

The fruit body is composed of numerous — sometimes several hundred — individual caps, each 1–4 centimetres across, deeply umbilicate, and light brown in color, forming the extremities of a strong, many-branched stalk. The compound fungus can reach up to 40 cm in diameter. The stalk is whitish-grey, 2.5–7 cm tall, and originates from a strong, underground, tuber-like nodule.

The fungus forms characteristic underground sclerotia — dense, irregularly shaped masses of hardened mycelium — which constitute the principal medicinal part of the organism. P. umbellatus has a wide distribution in temperate oak forests and is associated with broad-leaf, coniferous, and mixed coniferous forests, mostly found at altitudes ranging between 800 and 1500 m. Less common than the related species Grifola frondosa (Hen of the Woods), the fruitbodies of the Umbrella Polypore occur as fungal rosettes at the bases or on large underground roots of deciduous hardwood trees, and most often on oaks. This fungus is parasitic and attacks living trees, causing white rot. Trees can live for several years with this fungal infection, so fruitbodies may recur for a number of seasons.

Medicinal Part and Common Preparations

The sclerotium — called Zhuling in TCM — is the crude drug commonly used for urological disorders in Chinese medicine because of its diuretic effect, i.e., promoting urination. Numerous TCM preparations containing the sclerotia or sclerotia extract of P. umbellatus have been included in the 2020 Chinese Pharmacopoeia, including Wuling powder, Zhuling tang, Zhuling wan, Fenxiao tang, and Yinchen Wuling powder. The edible fruiting body — sometimes termed "Zhuling flower" in Chinese — occurs rarely in the natural environment. The mycelia, another form, have typically been obtained through liquid fermentation.

Modern commercial preparations include dried sclerotia powder, standardized polysaccharide extracts, hot-water (aqueous) extracts, alcohol (ethanolic) extracts, and injectable polysaccharide formulations. Decoctions or alcohol extracts of these prescription drugs have shown efficacy in clinical application by oral administration. Due to its promising medicinal value, P. umbellatus is used as an ingredient in many medicinal products and food supplements.

2. Traditional and Historical Use

Traditional Chinese Medicine

The use of Polyporus umbellatus in China can be traced back to the Han Dynasty. It was described in several famous Chinese medical books, including Shen Nong's Herbal Classic (Shen Nong Ben Cao Jing), Chinese Materia Medica (Zhong Hua Ben Cao), Treatise on Cold Pathogenic Diseases (Shang Han Lun), and Compendium of Materia Medica (Ben Cao Gang Mu). The sclerotia has been documented in the Shen Nong's Canon of Materia Medica, which dates back to approximately 2,000 years ago, to have been used for medicinal purposes.

Various ancient books recorded Polyporus umbellatus being used for treating edema and promoting diuretic processes. In TCM practice, Polyporus umbellatus has been used as a diuretic for the treatment of various kidney diseases associated with edema, scanty urine, vaginal discharge, cloudy painful urinary dysfunction, and diarrhea.

In TCM theory, Polyporus umbellatus mushroom is sweet, bland, and neutral in nature, entering the kidney and bladder meridians. It is considered an excellent diuretic herb that drains dampness and promotes water metabolism without harming qi and yin.

Unlike Poria cocos (Schw.) Wolf, which is commonly used for invigorating the spleen and calming the heart, P. umbellatus has been widely used in the treatment of edema, acute nephritis, and difficult urination, with many prescriptions containing it, such as Wuling San and Chailing Tang. The fungus is often paired with other traditional herbs such as Poria (Fu Ling), Alisma (Ze Xie), and Atractylodes (Bai Zhu) to enhance its effects; for instance, in the herbal formula Si Ling San (Four-Ingredient Powder with Poria), Chuling is combined with these ingredients to address conditions like edema and urinary disorders.

Use in Japan, India, and Other Countries

In addition to China, Polyporus umbellatus has also been used as a traditional medicine in Japan, India, and other countries for centuries for curing edema and as a diuretic. Many medical prescriptions containing Polyporus umbellatus, such as Wulingsan (WLS), Choreito, CGX, Sairei-to, and Yinchenwuling San, have been used to treat various kidney diseases in China, Japan, India, and other countries.

Official Pharmacopoeia Recognition

Polyporus umbellatus was listed in the Chinese Pharmacopoeia (2010 edition) and applied as a TCM to treat edema, acute nephritis, and diarrhea. It was also officially included in the 2020 edition of the Chinese Pharmacopoeia as a medication with therapeutic applications in treating dampness, diuresis, and reducing swelling.

3. Key Constituents and Active Compounds

Primary Chemical Classes

P. umbellatus is a species of mushroom that possesses a wide range of bioactive compounds including polysaccharides, terpenes, nucleosides, sterols, alkaloids, and several others. The main chemical constituents of P. umbellatus include polysaccharides and sterols, while secondary compounds include fatty acids, phenols, and other small molecules. Phytochemical studies have also confirmed the presence of many valuable secondary metabolites such as steroids, polysaccharides, anthraquinones, and nucleosides.

Polysaccharides (PUPs / PPS)

Among the pharmaceutical components — which include polysaccharides, ergosterols, biotin, proteins, and other molecules — Polyporus umbellatus polysaccharide (PUPS) has been identified as one of the major bioactive components. The major component in PUPS is a β-glucan with a (1→3)-β-glucose backbone and (1→6)-β-glucose side chains, with a molecular weight of approximately 1.6 × 10⁵ Da. Accumulating evidence has demonstrated that the P. umbellatus polysaccharides (PUPs) are the main and representative pharmacologically active ingredients, displaying multiple bioactivities both in vivo and in vitro, such as antioxidant, immunomodulatory, antitumor, anti-proliferative, and hepatoprotective effects. Many PUPs have been isolated from the different sources of P. umbellatus, including sclerotia, fruiting body, mycelia, and fermentation liquid.

A new water-soluble polysaccharide (HPP) with strong immunomodulatory activity was isolated from Polyporus umbellatus (Pers.) Fries. HPP has an average molecular weight of 6.88 kDa and is composed mainly of an α-(1→4)-linked D-galactan backbone.

Sterols: Ergosterol and Ergone

Among the active ingredients, ergosterol and polysaccharides are the most important functional components. The most important steroidal component is ergosterol, which is active in diuresis. The n-hexane extract of P. umbellatus provides significant diuretic activity, and the key compound is ergosta-4,6,8(14),22-tetraen-3-one, known as ergone — one of the bioactive steroids isolated from this extract. Aldosterone is a steroid hormone produced by the adrenal gland that regulates sodium and potassium balance in the blood; ergone has been shown to have an anti-aldosteronic diuretic effect.

In 2010, ergosterol was added to the Chinese Pharmacopoeia as a quality-control marker for crude samples of Polyporus umbellatus, measured by HPLC method; the content of ergosterol should not be less than 0.07%. Pharmacokinetic studies have demonstrated that ergosterol and ergone have high distribution and absorption in the plasma, and both main steroidal components of Polyporus umbellatus are mainly excreted by feces.

Polyporusterones

From the crude drug Chorei (the Japanese name for P. umbellatus), seven components named polyporusterone A, B, C, D, E, F, and G have been isolated. These compounds were found to be cytotoxic to leukemia cells. Some isolated compounds, such as polyporusterones A, B, and C, and ergone, have demonstrated cytotoxic activities against human tumor cell lines, notably liver cancer (Hep3B) and colon cancer (HT-29).

Other Notable Compounds

Other active ingredients isolated from P. umbellatus include emodin, chrysophanol, and ergosterol peroxide. The full spectrum of active ingredients encompasses triterpenoids, sterols, alkaloids, polypeptides, amino acids, polysaccharides, and organic acids. For hair growth activity (see below), 3,4-dihydroxybenzaldehyde was isolated from Polyporus umbellatus F. as one of its active hair-growth-promoting principles. A later study isolated three additional hair regrowth substances: acetosyringone and polyporusterone A and B.

Even within the fruiting bodies, sclerotium, and mycelium of P. umbellatus, there are structural, functional, and content differences in the active substances; among different specimens from the same origin, these active compounds also vary in terms of content, activity, and effectiveness; and there are also differences in composition and content at different growth stages.

4. Mechanisms of Action

Diuretic Mechanisms

Studies have found that aqueous extracts from P. umbellatus exert diuretic effects probably by inhibiting tubular reabsorption action. The active components responsible for diuresis in vivo are mainly from the ethanol extracts of P. umbellatus and the extracts of hexane, ethyl acetate, and n-butanol. Aldosterone is a steroid hormone produced by the adrenal gland that regulates sodium and potassium balance in the blood; ergone has been shown to have an anti-aldosteronic diuretic effect.

In a comparison experiment with furosemide — a diuretic widely used in clinical practice — an 8-day dose of P. umbellatus extract produced a diuretic effect comparable to that of furosemide, while excretion of the electrolytes Na⁺, K⁺, and Cl⁻ was significantly greater than that of furosemide.

Immunomodulatory Mechanisms

A polysaccharide from Polyporus umbellatus (PPS or PUP) can upregulate the co-expression of CD86 and CD11c on bone marrow dendritic cells (BMDCs) via TLR4, and significantly induce BMDCs to produce IL-12, which is the most powerful stimulator for NK cell activation. HPP — the homogeneous polysaccharide from P. umbellatus — can obviously increase the secretion of immune factors by IFN-γ-stimulated macrophages, including nitric oxide (NO), interleukin-6 (IL-6), interleukin-1β (IL-1β), RANTES, and interleukin-23 (IL-23), and the expression of the cell membrane molecule CD80.

Polyporus polysaccharide, which is the main ingredient in Polyporus umbellatus, has multiple pharmacological functions, including anticancer, immunoenhancing, radioprotective, and antioxidative activities. Research has shown that crude polyporus polysaccharide could suppress the growth of tumor cells via the TLR4/NF-κB pathway and greatly induce the transformation of M2 subtype macrophages to the M1 subtype in vitro.

Antitumor Mechanisms

Bladder cancer is a malignant tumor closely associated with immune dysfunction in macrophages, and P. umbellatus polysaccharide has been used as an antitumor drug for bladder cancer. The aqueous extract of P. umbellatus Fries was found to effectively inhibit bladder cancer, with polysaccharides identified as the main component responsible for this effect.

Hepatoprotective Mechanisms

Polysaccharides of P. umbellatus produce significant hepatoprotective activity against hepatotoxicity caused by CCl₄ and D-galactosamine in mice. PPS (polyporus polysaccharide) can regulate the activity of glycogen isomerase in the organism, which in turn regulates gluconeogenesis to improve overall body function.

Nephroprotective Mechanisms

Ergone has been proven to prevent kidney injury and the subsequent renal fibrosis. Research showed that a medicine containing P. umbellatus could lower high plasma glucose levels in diabetic rats, and also regulated diabetic-dependent alterations in urinary albumin, urinary albumin excretion rate, creatinine clearance, and glomerular mesangial matrix expansion.

5. Scientific Evidence by Area of Use

5.1 Diuretic Activity and Kidney Function

Pharmacological studies and clinical practice provide strong evidence for diuretic and treatment of various kidney diseases. Clinical studies have confirmed that Polyporus umbellatus is an effective diuretic, without side effects, for the treatment of pyelonephritis, nephritis, and urologic calculi. Polyporus umbellatus has been cited a number of times in the literature as a herbal drug used to prevent kidney stones (urolithiasis).

The fungus is distributed in Asia, Europe, and North America, and is used in China and other countries for centuries to treat a variety of chronic diseases, such as edema, scanty urine, cloudy painful urinary dysfunction, jaundice, and diarrhea. Earlier studies demonstrated that P. umbellatus possesses diuretic effect and protects against renal fibrotic effect.

Evidence strength: Most of the pharmacological studies have been conducted using crude and poorly characterized extracts of Polyporus umbellatus in animals, especially in the case of diuretic activities and the treatment of kidney diseases. The foundational clinical reports (e.g., Wang et al., 1964) predating rigorous modern trial design lack the controls and standardization of contemporary randomized controlled trials. Overall, evidence for diuretic activity is supported by animal, in vitro, traditional clinical use, and some older clinical reports, but well-designed modern RCTs are lacking.

5.2 Anticancer and Antitumor Activity

Polysaccharides extracted from the mycelial culture of P. umbellatus and administered intraperitoneally into white mice at a dosage of 300 mg/kg inhibited the growth of Sarcoma 180 and Ehrlich solid cancers by 70% and 80%, respectively (Ohtsuka et al., 1973). Chuling, together with mitomycin C, was found to increase the life span of tumor-bearing mice.

In an in vitro study, the mechanism of homogeneous polyporus polysaccharide (HPP) in activating macrophages in the treatment of bladder cancer was investigated, using 100 ng/mL phorbol myristate acetate (PMA) to induce THP-1 human leukemic cells as a macrophage model; macrophages derived from THP-1 were then treated with different concentrations of HPP (1, 10, and 100 μg/mL).

A Chinese study found that P. umbellatus polysaccharides can offset the immunosuppression of the supernatant from S180 cell culture, possibly by downregulating the synthesis and/or secretion of immunosuppressive substance by S180 cells.

In vivo studies have shown that doses of 200 to 400 mg/kg significantly reduce tumor size and prolong survival in mice with hepatomas.

In China, polysaccharide preparations derived from P. umbellatus have been licensed for use as adjuncts in cancer therapy. Given the efficacy of P. umbellatus in treating edema and supporting anti-tumor activities, clinical applications of drugs derived from P. umbellatus, such as the P. umbellatus polysaccharide injection and Wuling-san, have become widespread.

Evidence strength: Antitumor evidence is substantial in vitro and in animal models. The macrophage polarization studies, TLR4/NF-κB pathway work, and cancer cell cytotoxicity data represent a coherent mechanistic body of preclinical work. Clinical evidence in humans is limited and predominantly reflects Chinese clinical practice reports rather than internationally registered RCTs. Modern in vitro or in vivo pharmacological experiments and clinical practice for the efficacy of P. umbellatus provide strong support, and the separation of compounds has deepened people's understanding of this TCM.

5.3 Immunomodulation

Polyporus umbellatus polysaccharides were found to improve the cellular immunity of normal mice and mice with liver lesions. A water-soluble polysaccharide called Haishen polysaccharide peptide (HPP), found in P. umbellatus, was discovered to have strong immunomodulatory effects; it significantly increased the secretion of immune factors, such as nitric oxide (NO), interleukin-6 (IL-6), interleukin-1β (IL-1β), and interleukin-23 (IL-23), by macrophages stimulated with IFN-γ; it also enhanced the expression of the cell membrane molecule CD80.

Recently, PUPs, as one of the main bioactive components, have attracted significant attention because of their multiple health-promoting properties, such as antioxidant, immunomodulatory, antitumor, hepatoprotective, delaying of cellular aging, protection against DNA damage, and antimutagenic effects.

Evidence strength: Immunomodulatory effects are well-characterized at the in vitro and animal levels, with identified molecular targets (TLR4, NF-κB, dendritic cell activation, macrophage polarization). Human clinical trials specifically designed to quantify immunological endpoints in healthy or immunocompromised populations have not been widely reported in the international peer-reviewed literature.

5.4 Hepatoprotective Activity

Combined administration of polysaccharides from P. umbellatus and Salvia miltiorrhizae increases normalization rate of alanine transaminase and negative conversion rate of HBeAg in patients with chronic hepatitis B. Polysaccharides of P. umbellatus have the potential to treat chronic hepatitis B virus. Polysaccharides of P. umbellatus produce significant hepatoprotective activity against hepatotoxicity caused by CCl₄ and D-galactosamine in mice.

Evidence strength: Preclinical (animal/cell) evidence for liver protection is solid. The hepatitis B data, while intriguing, derive from older Chinese clinical reports (Xiong, 1993) and have not been replicated in modern controlled trials.

5.5 Nephroprotective Activity and Renal Fibrosis

P. umbellatus's chemical components contribute to the diverse pharmacological properties exhibited, such as diuretic activity, antitumor effects, liver protection, immune modulation, antiaging properties, protection against DNA damage, antimutagenic effects, improvement of renal function, and amelioration of renal collagen deposition and subsequent fibrosis. A 2021 study published in Frontiers in Pharmacology confirmed that ergone — a bioactive steroid isolated from P. umbellatus — has been proven to prevent kidney injury and the subsequent renal fibrosis.

Evidence strength: Mechanistic animal and in vitro studies demonstrate nephroprotective effects, particularly for ergone and polysaccharide fractions. Lipidomic analysis has identified specific fatty acyl metabolites modulated by P. umbellatus in the kidney. Prospective human clinical data are not yet available in the major international literature.

5.6 Hair Growth Promotion

In a study investigating the effects of methanol extracts of 80 herbs on hair growth using normal C3H/He mice from which telogen hair on the back had been removed, eighteen of the extracts apparently promoted hair regrowth. As one of the active principles in Polyporus umbellatus F., 3,4-dihydroxybenzaldehyde was isolated by column chromatography as a hair-growth-promoting agent. A later study isolated three hair regrowth substances: acetosyringone and polyporusterone A and B. Of these, polyporusterone A is said to be more effective in mammals and its crystal structure has been analyzed further.

Evidence strength: Preliminary, based entirely on animal (murine) models and in vitro isolation studies. No human clinical trials of P. umbellatus specifically for hair loss have been identified in the peer-reviewed literature.

5.7 Antioxidant Activity

The main free-radical scavengers identified include the triterpene carboxylic acids isolated from the methanol extract, polyporusterone A and polyporusterone B, which were found to have inhibitory activities against AAPH-induced lysis of red blood cells. Over the past few decades, researchers have found this taxon to contain many bioactive compounds shown to be responsible for antioxidant and free radical scavenging activities.

Evidence strength: In vitro antioxidant activity is well-documented. In vivo and clinical data are lacking.

5.8 Antimutagenic and DNA-Protective Activity

Among the pharmacological properties identified for P. umbellatus are antimutagenic effects and protection against DNA damage. PUPs have attracted attention for delaying cellular aging and protection against DNA damage.

Evidence strength: Reported in preclinical contexts only. Human evidence is absent.

6. Body Systems and Health Areas Associated with Polyporus

• Urinary system: Different extracts or isolated compounds of Polyporus umbellatus have demonstrated diuretic, nephroprotective, and hepatoprotective activities, among others. The urinary system — encompassing the kidneys, bladder, and urinary tract — is the primary traditional and pharmacological target of this mushroom.
• Immune system: Polyporus polysaccharide has multiple pharmacological functions, including immunoenhancing activities. Macrophage activation and dendritic cell stimulation are principal mechanisms.
• Liver: Polyporus polysaccharide has hepatoprotective activities. Traditional formulas use it for jaundice and liver-related conditions.
• Oncology (adjunctive): In China, the polysaccharide extract has been used as an adjuvant in cancer therapy, particularly for bladder cancer.
• Hair follicles: Preclinical evidence links polyporusterones A and B and other compounds to hair regrowth promotion.
• Cardiovascular/fluid metabolism: P. umbellatus demonstrates antiallergic effects and enhances microcirculation.

7. Dosage Forms and Reported Dosages

The following dosages are reported in the scientific and traditional literature and are not recommendations.

• Traditional decoction (TCM): In the clinical practice of TCM, it is usually used as a diuretic agent along with other crude drugs, such as Zhuling Tang, Zhuling San, and Wuling San. The sclerotia are prepared as water decoctions or alcohol extracts.
• Animal antitumor studies: Polysaccharides administered intraperitoneally into white mice at a dosage of 300 mg/kg inhibited the growth of Sarcoma 180 and Ehrlich solid cancers by 70% and 80%, respectively.
• Animal antitumor studies (hepatoma): In vivo studies have shown that doses of 200 to 400 mg/kg significantly reduce tumor size and prolong survival in mice with hepatomas.
• In vitro bladder cancer macrophage studies: Macrophages derived from THP-1 were treated with different concentrations of HPP (1, 10, and 100 μg/mL).
• In vitro bladder cancer co-culture: MB49 bladder cancer cells and RAW264.7 macrophages were co-cultured with or without HPP intervention at 50, 100, or 200 μg/mL for 24 hours.
• Reported clinical extract dose (edema): A reported clinical study showed that a dose of 400 mg/day improves renal function and reduces edema markers without notable side effects.
• Quality control standard: The content of ergosterol in Polyporus umbellatus crude drug should not be less than 0.07%, per the Chinese Pharmacopoeia.

8. Safety Considerations and Interactions

Overall Safety Profile

P. umbellatus has no or little side effect, which has confirmed the safety profile of this mushroom. Based on available reviews, there is no information on the side effects or toxicity — including acute toxicity, subacute toxicity, or chronic toxicity — from many years of research on Polyporus umbellatus.

At present, any adverse reaction of Polyporus umbellatus Fries in clinical application has not been reported, and PPS (polyporus polysaccharide) is a macromolecular component extracted from a relatively safe traditional Chinese medicine in clinical medication.

Research Limitations Regarding Safety

The pharmacological studies so far have mostly been performed in vitro and in vivo in animals. Hence, the evidence is limited, and clinical studies in humans are needed in order to fully assess the therapeutic potential and safety of Polyporus umbellatus. More experiments, including in vitro, in vivo, and clinical studies, should be encouraged to identify any side effects or toxicity.

Electrolyte Effects

The documented diuretic mechanism is notable from a safety perspective. Compared to furosemide, an 8-day dose of P. umbellatus extract produced greater excretion of the electrolytes Na⁺, K⁺, and Cl⁻. This implies that individuals taking P. umbellatus alongside other diuretics or electrolyte-sensitive medications should be aware of potential additive effects on fluid and electrolyte balance.

Pregnancy and Lactation

The use of Polyporus umbellatus in pregnant or breastfeeding women is not recommended in the absence of specific clinical safety data.

Anti-aldosterone Effects and Drug Interactions

Ergone has been shown to have an anti-aldosteronic diuretic effect. This mechanism suggests potential interactions with mineralocorticoid-active drugs (aldosterone antagonists such as spironolactone), though direct interaction studies have not been formally conducted in humans.

Immunomodulatory Interactions

The pharmacological activities of Polyporus umbellatus can be linked to the steroids — which confer diuretic, nephroprotective, anti-inflammatory, and antioxidative activities — and the polysaccharides, which confer anticancer, immuno-enhancing, and hepatoprotective activities. Given the macrophage-activating and pro-inflammatory cytokine-inducing properties of PUPs, the mushroom's polysaccharide components could theoretically interfere with immunosuppressive therapies, though no clinical interaction data exist.

Wild Collection Warning

Although P. umbellatus is an edible fungus, the polypore is so rare in the wild that it should not be collected for eating. Presently, wild sclerotia are the main source of medicinal material; the lack of effective protection, along with increasing commercial demand, has led to excessive harvest and a dramatic decline of wild resources in China.

9. Current Research Status and Limitations

Modern in vitro or in vivo pharmacological studies have demonstrated that Polyporus umbellatus possesses diuretic, nephroprotective, anticancer, immuno-enhancing, hepatoprotective, anti-inflammatory, and antioxidative activities. However, the overall body of evidence remains predominantly preclinical. The complex active substances also hinder research to some extent, as the mechanism of action and potential synergistic or antagonistic effects of the mixture of various active ingredients have not been clearly analyzed.

Modern phytochemical, pharmacological, and metabonomic investigations have shown that the crude extracts and isolated compounds from Polyporus umbellatus possess many kinds of biological functions, especially in diuretic activities and the treatment of kidney diseases, as well as anti-cancer, immuno-enhancing, and hepatoprotective activities. The pathways of distribution, absorption, metabolism, and excretion of main steroidal compounds were clarified by pharmacokinetic studies. The 2020 Chinese Pharmacopoeia listing and the wide clinical use of multi-ingredient formulas in East Asian medicine represent the most substantive formal regulatory recognition of its therapeutic role, but internationally harmonized clinical trial data remain sparse.

References

• Zhao YY. Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: a review. Journal of Ethnopharmacology, 2013. PubMed PMID: 23811047
• Phytochemistry and bioactivities of the main constituents of Polyporus umbellatus (Pers.) Fries. ScienceDirect / Phytomedicine, 2022. PubMed PMID: 35667259
• Liu GK, Yang TX, Wang JR. Polysaccharides from Polyporus umbellatus: A review on their extraction, modification, structure, and bioactivities. International Journal of Biological Macromolecules, 2021. PubMed PMID: 34419536
• Polyporus umbellatus, A Precious Rare Fungus With Good Pharmaceutical and Food Value. PMC / Frontiers in Pharmacology, 2025.
• Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites. PMC / Frontiers in Pharmacology, 2021.
• Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment. PMC / BMC Complementary Medicine and Therapies, 2021.
• Mechanisms of Macrophage Immunomodulatory Activity Induced by a New Polysaccharide Isolated From Polyporus umbellatus (Pers.) Fries. PMC / Frontiers in Chemistry, 2020.
• Immunomodulatory function and anti-tumor mechanism of natural polysaccharides: A review. PMC / Frontiers in Immunology, 2023.
• A systematic review of advances in preparation, structures, bioactivities, structural-property relationships, and applications of Polyporus umbellatus polysaccharides. PMC, 2025.
• Polyporus umbellatus – overview. ScienceDirect Topics.
• Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: A review. Journal of Ethnopharmacology, ScienceDirect, 2013.
• Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus. Journal of Ethnopharmacology, ScienceDirect, 2009.
• Polysaccharides from Polyporus umbellatus: A review on their extraction, modification, structure, and bioactivities. International Journal of Biological Macromolecules, ScienceDirect, 2021.
• Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via autophagy induction. Pharmaceutical Biology, Taylor & Francis, 2024.
• Mechanisms of Macrophage Immunomodulatory Activity Induced by a New Polysaccharide Isolated From Polyporus umbellatus (Pers.) Fries. Frontiers in Chemistry, 2020.
• Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites. Frontiers in Pharmacology, 2021.
• Polyporus umbellatus, an Edible-Medicinal Cultivated Mushroom with Multiple Developed Health-Care Products as Food, Medicine and Cosmetics: a review. Cryptogamie, Mycologie, Muséum national d'Histoire naturelle, 2015.
• Genetic Diversity and Evolution of Chinese Traditional Medicinal Fungus Polyporus umbellatus (Polyporales, Basidiomycota). PMC, 2013.
• Studies on active substances in herbs used for hair treatment. I. Effects of herb extracts on hair growth and isolation of an active substance from Polyporus umbellatus F. PubMed PMID: 8004697
• Polyporus umbellatus, Umbrella Polypore fungus. First Nature.
• Polyporus umbellatus (Umbrella Polypore): Benefits & Medicinal Uses. Healing-Mushrooms.net, 2021.